Mammographic screening sharply lowers the risk of breast cancer death over the long-term, according to a study published online June 28 in the journal Radiology.
Mammographic screening sharply lowers the risk of breast cancer death over the long-term, according to a study published online June 28 in the journal Radiology.
The study, which followed 133,056 women aged 40-74 for 29 years, divided women – all from two Swedish counties – into groups who received mammography and a control group who did not. The screening period lasted seven years, with women from 40-49 being screened every two years and those 50- 74 every 33 months.
For every 414 to 519 women undergoing mammogram screenings, one breast cancer death was prevented, found the team led by author Stephen W. Duffy, MSc, of Queen Mary University of London.
"In this study, we've continued to monitor women for nearly three decades and we've found that the longer we look, the more lives are saved," Duffy said in a statement.
The study represents a statistical counterpoint to the U.S. Preventative Task Force’s controversial 2009 recommendation to eliminate routine breast-cancer screening for women in their 40s. Breast Cancer is the second most lethal of cancers among women, behind only lung cancer.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.